✦ LIBER ✦

Antitumor activity of combination treatment combining gemcitabine with cisplatin or vindesine against human lung cancer xenografted in nude mice

Book ID: 122099822
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 144 KB
Volume: 12
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(95)98944-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acquired resistance and cross-resistance

Acquired resistance and cross-resistance of gemcitabine to cisplatin or vindesine in human lung cancer xenografted in nude mice

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Synergistic antitumor activity of combin

Synergistic antitumor activity of combination chemotherapy with mitomycin C and cisplatin against human gastric cancer xenografts in nude mice

✍ Yoshiro Saikawa; Dr. Tetsuro Kubota; Tsong-Hong Kuo; Toshiharu Furukawa; Suguru 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB

A new combined cancer chemotherapy regimen of mitomycin C (MMC) and cisplatin (DDP) showed synergistic antitumor activity against human gastric cancer xenografts St-40 and SC-1-NU in BALB/c nu/nu mice. The drugs were administered intraperitoneally at doses of 2 or 4 mg/kg for MMC and 3 or 6 mg/kg fo

Enhanced antitumor activity of irofulven

Enhanced antitumor activity of irofulven in combination with gemcitabine against the MV522 human lung carcinoma xenograft

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Combination chemotherapy with mitomycin,

Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer association of antitumor activity with initial tumor burden and treatment center

✍ Rudolf A. Joss; Kurt Bürki; Peter Dalquen; Ernst Schatzmann; Serge Leyvraz; Fran 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 878 KB

Combination chemotherapy with mitomycin,

Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 169 KB

The antitumor activity of NK012, an SN-3

The antitumor activity of NK012, an SN-38–incorporating micelle, in combination with bevacizumab against lung cancer xenografts

✍ Hirotsugu Kenmotsu; Masahiro Yasunaga; Koichi Goto; Tatsuya Nagano; Jun-ichiro K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 974 KB

## Abstract ## BACKGROUND: It has been demonstrated that NK012, a novel 7‐ethyl‐10‐hydroxycamptothecin (SN‐38)‐incorporating polymeric micelle, exerts significantly more potent antitumor activity against various human tumor xenografts than irinotecan (CPT‐11) (a water‐soluble prodrug of SN‐38). Co